Trends in prevalence, treatment use, and disease burden in patients with eosinophilic granulomatosis with polyangiitis in Japan: real-world database analysis.

Ken-Ei SadaTakeo SuzukiSandra JoksaiteShinyoung JuJohn LogieGeorge MuJeremiah HweeHideaki KunishigeTakeo IshiiAmit AdlakHarini VadlamudiRafael Alfonso-Cristancho

Published in: Modern rheumatology (2023)

EGPA prevalence increased between 2005 and 2020. With the introduction of mepolizumab for EGPA in 2018, real-world OCS use, relapses and HCRU decreased.

Keyphrases

risk factors
combination therapy
data analysis